Supply Notice – Delmosart (methylphenidate) 18mg prolonged-release tablets

Supply Notice – Delmosart (methylphenidate) 18mg prolonged-release tablets

November 1, 2019

Ref: MSN/2019/002
Tier 2 – medium impact
Date of issue 1st November 2019

The Department of Health and Social Care (DHSC) have today advised that Delmosart 18mg prolonged-release tablets are out of stock until mid-November 2019. All other strengths remain available, along with all other brands.

Action required 

  • For patients without sufficient supplies of Delmosart® 18mg tablets to last until the resolution date, prescribers may consider switching to an alternative brand of methylphenidate 18mg prolonged-release tablets (listed below):
    • Concerta XL® 18mg prolonged-release tablets
    • Matoride XL® 18mg prolonged-release tablets
    • Xaggitin XL® 18mg prolonged-release tablets
    • Xenidate XL® 18mg prolonged-release tablets

Supporting Information

  • UK Medicines Information has confirmed a switch to one of the above brands is bioequivalent and clinically appropriate, there are no licensed indication differences and no dosing adjustments are required.


If you have any queries, please contact

For more information on medicines shortages, click here.

To report a medicine shortage, click here.

Posted in: ,

More Latest News >

CPCS Frequently Asked Questions

With the Community Pharmacist Consultation Service (CPCS) now bedding in, below you will find a selection of questions about the...

CPCS: CPD opportunities

As announced in the 5-year CPCF agreement, NHS England & NHS Improvement and Health Education England (HEE) will use funding...